Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFN
Open Access
- 8 March 2004
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 199 (6), 775-784
- https://doi.org/10.1084/jem.20031591
Abstract
Toll-like receptors are important in the activation of innate immunity, and CD40 is a molecule critical for many T and B cell responses. Whereas agonists for either pathway have been used as vaccine adjuvants, we show that a combination of Toll-like receptor (TLR)7 and CD40 agonists synergize to stimulate CD8+ T cell responses 10–20-fold greater than the use of either agonist alone. Antigen-specific CD8+ T cells elicited from combination CD40/TLR7 treatment demonstrated both lytic activities and interferon (IFN)γ production and an enhanced secondary response to antigenic challenge. Agonists for TLRs 2/6, 3, 4, and 9 also synergized with CD40 stimulation, demonstrating that synergy with the CD40 pathway is a property of TLR-derived stimuli in general. The CD8+ T cell expansion induced by CD40/TLR7 triggering was independent of CD4+ T cells, IFNγ, and IL-12 but dependent on B7-mediated costimulation and surprisingly on type I IFN. These studies provide the rational basis for the use of TLR and CD40 agonists together as essential adjuvants to optimize vaccines designed to elicit protective or therapeutic immunity.Keywords
This publication has 62 references indexed in Scilit:
- Cross-priming of CD8+ T cells stimulated by virus-induced type I interferonNature Immunology, 2003
- Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848Nature Immunology, 2002
- Interferon-α and Interleukin-12 Are Induced Differentially by Toll-like Receptor 7 Ligands in Human Blood Dendritic Cell SubsetsThe Journal of Experimental Medicine, 2002
- Phenotypic and Functional Analysis of Cd8+ T Cells Undergoing Peripheral Deletion in Response to Cross-Presentation of Self-AntigenThe Journal of Experimental Medicine, 2001
- In VivoandIn VitroInterferon Induction in Chickens by S-28828, an Imidazoquinolinamine ImmunoenhancerJournal of Interferon & Cytokine Research, 1996
- Immunomodulating and antiviral activities of the imidazoquinoline S-28463Antiviral Research, 1995
- Activation of human dendritic cells through CD40 cross-linking.The Journal of Experimental Medicine, 1994
- Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivoImmunity, 1994
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- Antigen‐presenting Cells for CD8+ T CellsImmunological Reviews, 1990